Results 261 to 270 of about 310,541 (335)
Novel mutation associated with non‐compaction ventricular myocardium: A case report
ESC Heart Failure, EarlyView.
Yan Li +4 more
wiley +1 more source
Epicardial adipose tissue (EAT) has been linked to adverse remodelling and outcomes in aortic valve stenosis (AS), yet mechanisms remain unclear. In 137 patients with severe AS undergoing CMR before TAVR, higher EAT (≥46.5 ml/m2) was associated with impaired left atrial (LA) reservoir strain, while ventricular morphology, function and tissue ...
Judith Gronwald +10 more
wiley +1 more source
Cardiovascular resource utilization in patients with diastolic dysfunction: A retrospective cohort analysis. [PDF]
Howard A +12 more
europepmc +1 more source
Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study
Abstract Aims Inflammation is postulated to be a key pathogenic mechanism in heart failure with preserved ejection fraction (HFpEF). Soluble urokinase plasminogen activator receptor (suPAR), a regulator of innate immune activity, is associated with incident heart failure; however, its role in HFpEF remains unclear.
Christina G. Hutten +9 more
wiley +1 more source
Artificial intelligence improves detection and classification of pulmonary venous hypertension related to left ventricular diastolic dysfunction by chest radiography. [PDF]
White RD +9 more
europepmc +1 more source
Abstract Purpose Finerenone, a highly selective non‐steroidal mineralocorticoid receptor antagonist, was approved for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (diabetic kidney disease, DKD). Finerenone reduced the composite endpoint of heart failure events and cardiovascular death in patients with heart ...
Kristian Hellenkamp +9 more
wiley +1 more source
Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunction. [PDF]
Ratwatte S +4 more
europepmc +1 more source
Circulating oxylipins predict mortality in heart failure with preserved ejection fraction
A targeted LC–MS lipidomics approach identified arterial 15‐keto PGF2a as associated with 5‐year mortality in 90 patients with HFpEF. Abstract Aims Heart failure with preserved ejection fraction (HFpEF) poses significant diagnostic, prognostic and therapeutic challenges, with high morbidity and mortality rates.
Vaishnavi Aradhyula +12 more
wiley +1 more source

